financetom
Business
financetom
/
Business
/
US accuses Walgreens of filling unlawful opioid prescriptions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US accuses Walgreens of filling unlawful opioid prescriptions
Jan 17, 2025 3:02 PM

Jan 17 (Reuters) -

The U.S. Justice Department on Friday accused pharmacy chain

operator Walgreens Boots Alliance ( WBA ) of contributing to the

U.S. opioid epidemic by filling millions of unlawful

prescriptions for addictive painkillers and other drugs.

The department

intervened

in a whistleblower lawsuit filed in federal court in

Chicago and accused Walgreens of ignoring "red flags" and

filling prescriptions for opioids and other controlled

substances that lacked a legitimate medical purpose.

"These practices allowed millions of opioid pills and

other controlled substances to flow illegally out of Walgreens

stores," Brian Boynton, the head of the Justice Department's

Civil Division, said in a statement.

The lawsuit alleged that by knowingly filling unlawful

prescriptions for controlled substances, Walgreens violated the

Controlled Substances Act. The government also alleged it

violated the False Claims Act when it then sought reimbursement

from federal health care programs, like Medicare, for the

prescriptions.

The lawsuit was announced after Walgreens filed its own

lawsuit on Thursday challenging what it said were new policies

the U.S. Drug Enforcement Administration had unlawfully adopted,

seeking to ensure pharmacies do not dispense controlled

substances for medically illegitimate purposes.

That lawsuit was filed in federal court in Tyler, Texas,

following what Walgreens had described as recently as last week

as active negotiations with the Justice Department for a

potential settlement to resolve claims it improperly dispensed

opioids.

The company's lawsuit targeted what Walgreens called new,

"arbitrary" rules the DEA imposed without going through the

required rulemaking process.

"We will not stand by and allow the government to put our

pharmacists in a no-win situation, trying to comply with 'rules'

that simply do not exist," Walgreens said in a statement.

Walgreens is among the drug manufacturers, distributors,

pharmacy operators and others who have collectively in recent

years agreed to pay about $50 billion to resolve lawsuits and

investigations by states and local governments accusing them of

helping fuel a deadly opioid addiction epidemic in the U.S.

The U.S. Centers for Disease Control and Prevention says

nearly 727,000 opioid overdose deaths occurred from 1999 to

2022.

The Justice Department last month announced a similar

lawsuit against Walgreens rival CVS that accused the

pharmacy chain of filling illegal opioid prescriptions and

contributing to a nationwide epidemic of opioid addiction.

Walgreens in 2022 agreed to pay up to $5.52 billion over 15

years to resolve thousands of lawsuits by state and local

governments accusing the company of fueling the U.S. opioid

epidemic.

Last month, Ohio's top court overturned a $650.9 million

judgment two local counties secured against Walgreens, CVS and

Walmart ( WMT ) in the first case to go to trial nationally over

allegations the pharmacies contributed to the epidemic.

(Reporting by Nate Raymond in Boston, Editing by Alexia

Garamfalvi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Pixelworks Announces Definitive Purchase Agreement To Sell Its Shanghai Semiconductor Subsidiary To VeriSilicon
BRIEF-Pixelworks Announces Definitive Purchase Agreement To Sell Its Shanghai Semiconductor Subsidiary To VeriSilicon
Oct 15, 2025
Oct 15 (Reuters) - Pixelworks Inc ( PXLW ): * PIXELWORKS ANNOUNCES DEFINITIVE PURCHASE AGREEMENT TO SELL ITS SHANGHAI SEMICONDUCTOR SUBSIDIARY TO VERISILICON * PIXELWORKS INC ( PXLW ) - SALE VALUED AT RMB 950 MILLION OR $133 MILLION USD * PIXELWORKS INC ( PXLW ) - EXPECTS $50 MILLION-$60 MILLION CASH FROM SALE Source text: Further company coverage: ...
Taseko Says Wellfield Operations at Florence Copper Project Starting; Details Gibraltar Mine Q3 Output
Taseko Says Wellfield Operations at Florence Copper Project Starting; Details Gibraltar Mine Q3 Output
Oct 15, 2025
09:02 AM EDT, 10/15/2025 (MT Newswires) -- Taseko Mines ( TGB ) said Wednesday that it has received final regulatory approvals and is starting wellfield operations at its 100%-owned Florence Copper project in Arizona. The SX/EW plant was substantially completed on Sept. 19, with commissioning set to occur concurrently with the start of wellfield operations, and the first copper cathode...
Belite Bio Says China Accepts Tinlarebant NDA for Priority Review
Belite Bio Says China Accepts Tinlarebant NDA for Priority Review
Oct 15, 2025
09:01 AM EDT, 10/15/2025 (MT Newswires) -- Belite Bio ( BLTE ) said Wednesday that China's National Medical Products Administration has agreed to review its New Drug Application for Tinlarebant to treat Stargardt disease under a priority review. The company said the acceptance is based on interim results from its phase 3 Dragon study, which showed statistical significance in the...
Urano Energy Confirms Historical Uranium Inventory at Green River Project in Utah
Urano Energy Confirms Historical Uranium Inventory at Green River Project in Utah
Oct 15, 2025
09:01 AM EDT, 10/15/2025 (MT Newswires) -- Urano Energy ( UECXF ) Wednesday confirmed a significant historical uranium inventory at the Green River project in Utah. The company said it has identified multiple high-priority areas for follow-up exploration. An independent consulting mining engineer to Atlas estimated historical resources of 247,711 pounds of uranium grading 0.13%, along with additional historical resources...
Copyright 2023-2026 - www.financetom.com All Rights Reserved